Sodium Sulfacetamide 8% and Sulfur 4% SULFACETAMIDE SODIUM SULFUR AKRON PHARMA INC. FDA Approved Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is: Each mL of Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension contains 80 mg of Sodium Sulfacetamide and 40 mg of Sulfur in a formulation containing aloe vera gel, benzyl alcohol, butylated hydroxytoluene, cetyl alcohol, glyceryl monostearate, green tea extract, magnesium aluminum silicate, PEG- 40 stearate, phenoxyethanol, polyethylene glycol 400, polyethylene glycol 150, propylene glycol, purified water, sodium lauryl sulfate, sodium thiosulfate, stearyl alcohol, xanthan gum struct
FunFoxMeds bottle
Route
TOPICAL
Package NDC

Drug Facts

Composition & Profile

Strengths
8 % 4 % 473 ml
Quantities
473 ml
Treats Conditions
Indications Sodium Sulfacetamide 8 Sulfur 4 Topical Suspension Is Indicated In The Topical Control Of Acne Vulgaris Acne Rosacea And Seborrheic Dermatitis

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UNII
4NRT660KJQ 70FD1KFU70
Packaging

HOW SUPPLIED Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is available in 16 fl oz (473 mL) bottles, NDC 71399-0487-6.; SS84

Package Descriptions
  • HOW SUPPLIED Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is available in 16 fl oz (473 mL) bottles, NDC 71399-0487-6.
  • SS84

Overview

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is: Each mL of Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension contains 80 mg of Sodium Sulfacetamide and 40 mg of Sulfur in a formulation containing aloe vera gel, benzyl alcohol, butylated hydroxytoluene, cetyl alcohol, glyceryl monostearate, green tea extract, magnesium aluminum silicate, PEG- 40 stearate, phenoxyethanol, polyethylene glycol 400, polyethylene glycol 150, propylene glycol, purified water, sodium lauryl sulfate, sodium thiosulfate, stearyl alcohol, xanthan gum struct

Indications & Usage

INDICATIONS Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Dosage & Administration

Apply Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension sooner or using less often.

Warnings & Precautions
WARNINGS Although rare, sensitivity to sodium sulfacetaminde may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. FOR EXTERNAL USE ONLY . Keep away from eyes. Keep out of reach of children. Keep container tightly closed.
Contraindications

: Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 8% - Sulfur 4% Topical Suspension is not to be used by patients with kidney disease.

Adverse Reactions

Although rare, sodium sulfacetamide may cause local irritation.

Storage & Handling

Store at controlled room temperature, 15° - 30°C (59° - 86°F). Protect from freezing. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. All prescription substitutions using this product shall be made subject to state and federal statutes as applicable. NOTE: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation information provided herein. QUESTIONS? Please Call 1(877) 225-6999 Manufactured for: Akron Pharma, Inc. Fairfield, NJ 07004 Manufactured in U.S.A


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →